Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series ; volume:19 ; number:1 ; day:28 ; month:10 ; year:2019 ; pages:1-7 ; date:12.2019
BMC cancer ; 19, Heft 1 (28.10.2019), 1-7, 12.2019

Creator: Souadka, Amine
Majbar, Mohammed Anass
Benkabbou, Amine
Serji, Badr
Souiki, Tarik
Bouchentouf, Sidi Mohammed
Abid, Mourad
Khannousi, Basma El
Harroudi, Tijani El
Malki, Hadj Omar El
Raiss, Mohammed
Ifrine, Lahsen
Mazaz, Khalid
Zentar, Aziz
Mohsine, Raouf
Souadka, Abdelilah
Belkouchi, Abdelkader
Ahallat, Mohammed
Hrora, Abdelmalek

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12885-019-6239-3

URN: urn:nbn:de:101:1-2020022618344884547559

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:59 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Souadka, Amine
Majbar, Mohammed Anass
Benkabbou, Amine
Serji, Badr
Souiki, Tarik
Bouchentouf, Sidi Mohammed
Abid, Mourad
Khannousi, Basma El
Harroudi, Tijani El
Malki, Hadj Omar El
Raiss, Mohammed
Ifrine, Lahsen
Mazaz, Khalid
Zentar, Aziz
Mohsine, Raouf
Souadka, Abdelilah
Belkouchi, Abdelkader
Ahallat, Mohammed
Hrora, Abdelmalek
SpringerLink (Online service)

Other Objects (12)

Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

Neoadjuvant Therapy and Surgery in Rectal Adenocarcinoma: Analysis of Patients with Complete Tumor Remission

Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma

Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival

Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

Neoadjuvant Therapy and Surgery in Rectal Adenocarcinoma: Analysis of Patients with Complete Tumor Remission

Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma

Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival

Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

Neoadjuvant Therapy and Surgery in Rectal Adenocarcinoma: Analysis of Patients with Complete Tumor Remission

Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma

Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

Neoadjuvant Therapy and Surgery in Rectal Adenocarcinoma: Analysis of Patients with Complete Tumor Remission

Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma

Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival

Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

Neoadjuvant Therapy and Surgery in Rectal Adenocarcinoma: Analysis of Patients with Complete Tumor Remission

Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma

Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival

Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma

Role of 18F-PET-CT to predict pathological response after neoadjuvant treatment of rectal cancer

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma

Neoadjuvant Therapy and Surgery in Rectal Adenocarcinoma: Analysis of Patients with Complete Tumor Remission

Mucinous histology is a negative predictor of neoadjuvant chemoradiotherapy for locally advanced rectal adenocarcinoma

Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

Metformin increases pathological responses to rectal cancers with neoadjuvant chemoradiotherapy: a systematic review and meta-analysis

The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy

Association of pre-surgery to pre-radiotherapy lymphocyte counts ratio with disease-free survival in rectal cancer patients receiving neoadjuvant concurrent chemoradiotherapy

Complete pathological response following neoadjuvant FOLFOX chemotherapy in BRCA2-mutant locally advanced rectal cancer: a case report

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival

Related objects

Reset password